IMVT Immunovant Inc Total Asset Value of Company
Immunovant, Inc. (IMVT) relies on fixed R&D expenditures with the potential for monopoly profit growth. The asset and resource structure visualizes this trend, where the 756.99 mark serves as the current indicator. Success is based on antibody efficiency and patent protection, while a neutral geopolitical backdrop and diversified supplies ensure the company's stable development in the global market.
Analytical breakdowns and data insights for company Immunovant Corp (IMVT)
- share price and expert price forecast:
- market capitalization data:
- issuer book value statistics:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Immunovant, Inc.|IMVT - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Immunovant Therapeutics|IMVT - Company Aggregate Debts|Debts to Book Capitalization Immunovant Therapeutics|IMVT - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Immunovant|Interim Coverage Ratio immunovant.com
- net income and valuation multiples indicators:
Fundamental valuation:Immunovant, Inc.
The growth of total resources through the lens of return on assets determines the business's scaling potential and its resilience to market shocks. By analyzing the asset dynamics of Immunovant, Inc. (IMVT), an investor can see the total capital and liabilities, which is critically important for Immunovant, Inc. (IMVT) when assessing the liquidity reserve required to fund the development of the drug IMVT-1402 and the conduct of clinical trials.
Key competitors
ARGX: Aggregate Business Assets|Aggregate Company Assets BioNTech|Abivax - Total Asset Value of Company|Company Total Assets ADMA|PTGX (Protagonist Corp) - Aggregate Asset Value|Company Total Assets KNSA (Kiniksa Pharmaceuticals)|Company Total Assets grifols.com GRFS|ADPT - Aggregate Company Assets|Aggregate Asset Value CLDX (Celldex Therapeutics Inc)|Aurinia Pharma (AUPH) - Aggregate Company Assets|Cumulative Company Assets BioCryst Corp|VERA (Vera Therapeutics, Inc.) - Company Total Assets|Company Total Assets dianthustx.com|Cumulative Company Assets PHVS (Pharvaris)|ABCL (AbCellera Biologics) - Aggregate Asset Value|Company Total Assets TRML (Tourmaline Corp)|Company Total Asset Base Precigen Corp (PGEN)|PHAR - Aggregate Company Assets|nektar.com (NKTR) - Cumulative Company Assets|Upstream Bio (UPB) - Aggregate Company Assets|Cumulative Company Assets Zenas Bio|Cumulative Company Assets IMNM|Company Total Assets Gossamer Bio Corp.|Aggregate Company Assets KalVista Pharmaceuticals (KALV)|septerna.com - Total Business Assets|Company Total Assets PVLA (Pieris Pharmaceuticals, Inc.)|Savara Inc (SVRA) - Company Assets|Rigel Pharmaceuticals Inc - Company Total Assets|Company Total Asset Base AnaptysBio Inc. ANAB|Astria Therapeutics (ATXS) - Aggregate Company Assets|Cumulative Company Assets engene.com|Aggregate Company Assets RAPT Therapeutics|Cumulative Company Assets Aerovate (JBIO)|Cumulative Company Assets ACRS (Aclaris)|Company Total Assets Kyverna Therapeutics, Inc (KYTX)|Aggregate Company Assets Tiziana Life Sciences TLSA|CABA: Total Business Assets|VTYX - Aggregate Company Assets|Company Assets Theratechnologies, Inc.|AVTX (Avalo Therapeutics Inc.) - Cumulative Company Assets|ELDN (Eledon Pharmaceuticals, Inc) - Aggregate Company Assets|AGEN (Agenus) - Company Total Assets|Company Total Assets climbbio.com|Aggregate Company Assets Zura Bio (ZURA)|aTyr Pharma Inc - Total Business Assets|Adagene Inc. - Cumulative Company Assets|Aggregate Business Assets IMA (ImageneBio)|STTK: Cumulative Company Assets|Aggregate Asset Value EQ (Equillium, Inc.)|CNTB: Company Total Assets|IMUX - Company Total Asset Base|Aggregate Company Assets Atara Biotherapeutics, Inc.|Total Business Assets IFRX (InflaRx GmbH)|Company Total Assets XFOR|Cumulative Company Assets adicetbio.com ACET|Celularity - Cumulative Company Assets|Company Total Asset Base INmune Bio Inc (INMB)|Barinthus Bio - Company Total Assets|Company Total Asset Base Kezar Life Sciences Inc KZR|SAB Biotherapeutics (SABS) - Aggregate Company Assets|Cumulative Company Assets akaritx.com|Cumulative Company Assets ENLV|Aggregate Company Assets QTTB|Cumulative Company Assets GOVX (GeoVax Labs Inc)|Aggregate Business Assets EDSA|Aggregate Company Assets iBio, Inc. IBIO|CARM (Carisma Therapeutics Inc) - Total Asset Value of Company|XTL Biopharmaceuticals Ltd. - Company Total Assets|Aggregate Asset Value BOLT (Bolt Biotherapeutics)|HCWB: Company Total Assets|Aptevo Therapeutics Inc. (APVO) - Company Total Assets|Aggregate Company Assets AIM ImmunoTech Inc.|ADTX: Aggregate Asset Value|Aggregate Company Assets GRI Bio (GRI)|Cumulative Company Assets XORTX Therapeutics Inc XRTX|Company Total Assets HIND (ReShape Lifesciences)|Company Total Assets Revelation Biosciences Corp REVB|INDP: Cumulative Company Assets|Aggregate Asset Value SCNI (scinai.com)|CALI: Company Total Assets|AFMD - Company Total Asset Base|Aggregate Company Assets Allakos Inc|Cumulative Company Assets HOOKIPA (HOOK)|Aggregate Company Assets IGM Biosciences, Inc. (IGMS)|Cumulative Company Assets iteostherapeutics.com ITOS|Ocean Biomedical - Cumulative Company Assets|Company Total Assets TC BioPharm (Holdings) Plc TCBP|THRD - Aggregate Company Assets